A practical reference on Heptapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-25. Anything still debated is marked as such rather than presented as settled.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic cyclic heptapeptide | Analog of alpha-MSH with an internal lactam bridge |
| Molecular weight | Approximately 1024 daltons | Free base value; salt forms differ |
| Appearance | White to off-white powder | Usually supplied as a lyophilized solid |
| Solubility | Freely soluble in water | Poorly soluble in nonpolar solvents |
| Typical storage | −20 °C, dry, protected from light | Repeated freeze-thaw cycles degrade peptides |
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
=== Synthesis === Loperamide is synthesized starting from the lactone 3,3-diphenyldihydrofuran-2(3H)-one and ethyl 4-oxopiperidine-1-carboxylate, on a lab scale. On a large scale a similar synthesis is followed, except that the lactone and piperidinone are produced from cheaper materials rather than purchased.
== External links == Clinical trial number NCT02290873 for "A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients" at ClinicalTrials.gov Clinical trial number NCT02296892 for "A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy" at ClinicalTrials.gov Clinical trial number NCT02532647 for "Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy" at ClinicalTrials.gov
In animals and humans, serotonin is synthesized from the amino acid L-tryptophan by a short metabolic pathway consisting of two enzymes, tryptophan hydroxylase (TPH) and aromatic amino acid decarboxylase (DDC), and the coenzyme pyridoxal phosphate. The TPH-mediated reaction is the rate-limiting step in the pathway. TPH has been shown to exist in two forms: TPH1, found in several tissues, and TPH2, which is a neuron-specific isoform. Serotonin can be synthesized from tryptophan in the lab using Aspergillus niger and Psilocybe coprophila as catalysts. The first phase to 5-hydroxytryptophan would require letting tryptophan sit in ethanol and water for 7 days, then mixing in enough HCl (or other acid) to bring the pH to 3, and then adding NaOH to make a pH of 13 for 1 hour. Aspergillus niger would be the catalyst for this first phase. The second phase to synthesizing tryptophan itself from the 5-hydroxytryptophan intermediate would require adding ethanol and water, and letting sit for 30 days this time. The next two steps would be the same as the first phase: adding HCl to make the pH = 3, and then adding NaOH to make the pH very basic at 13 for 1 hour. This phase uses the Psilocybe coprophila as the catalyst for the reaction.
Although studies are lacking, a handful of case reports suggest that abrupt discontinuation of bupropion may cause antidepressant discontinuation syndrome. Rarely, bupropion has been associated with induction of compulsive behavior.
Sources: en.wikipedia.org
OPD (o-phenylenediamine dihydrochloride) turns amber to detect HRP (horseradish peroxidase), which is often used to as a conjugated protein. TMB (3,3',5,5'-tetramethylbenzidine) turns blue when detecting HRP and turns yellow after the addition of sulfuric or phosphoric acid. ABTS (2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt) turns green when detecting HRP. PNPP (p-Nitrophenyl Phosphate, Disodium Salt) turns yellow when detecting alkaline phosphatase.
Lactobacillus delbrueckii subsp. lactis is a subspecies of Lactobacillus delbrueckii that is generally used to measure the amount of cobalamin in food. Its growth rate is proportional to the amount of cobalamin in the growth medium. However, lactis has been demonstrated to have the option to utilize pseudocobalamin, which is inactive for humans, as well as "alkali-resistant factors" (deoxyribosides and deoxynucleotides), leading to an overestimation of the amount of cobalamine in food. As such, new methods using HPTLC or LC-MS/MS have also been developed.
Looking at HM Prison Deerbolt in County Durham and Maudsley Hospital in South London, and divorce and one-parent families had different effects; Iain Duncan Smith talks of being 'victims in society of a social experiment over many decades'; Jonathan Sacks, Baron Sacks talking of a 'national consensus that something was missing in the moral environment'; there was a belief that juvenile crime was linked to single parents and broken homes; Michael Anderson, Professor of Economic History at the University of Edinburgh, claimed that it was all due to current politicians wanting to nostalgically return to a 'golden age' of civility, and he inferred that 'Victorian values' had no importance; a training session for single parents in Maudsley Hospital in Southwark; Michael Wadsworth (sociologist) and the National Survey of Health & Development, which had around 5,000 on the cohort study, and had been set up for establishing the NHS - it showed that divorce increased chances of divorce in children, and of delinquency in children; Martin Richards (psychologist) of the University of Cambridge's Centre for Family Research, and the 1958 National Child Development Study, which looked all of the 17,000 born in one week in early March, and showed similar results to the previous study; the Marriage Research Centre began a study of 65 married couples in 1979; Penny Mansfield CBE of OnePlusOne said that women, after entering the workplace in greater numbers, were now having higher expectations of men's contribution to a marriage; the divorce rate was now 40%, with 33% of divorces occurring in the first five years of marriage; lone parents were now 19% of all British families; for children of divorced parents, 95% would stay with the mother, and within two years, 50% of these children would lose contact totally with their father; Prof John Newson, husband of Elizabeth Newson, and the Child Development Research Unit, founded in 1958 at the University of Nottingham - he said that juvenile delinquency was heavily related to the lower social classes - for the bottom two social classes, one quarter of the children receive a criminal record; David P. Farrington and Donald J. West of the University of Cambridge, conducted a study of 400 London boys born in 1953, known as the Cambridge Study in Delinquent Development; in the study, 37% of all boys acquired a criminal record, but of those with three known determining factors, 75% had a criminal record; 50% of the crime in the study was conducted by only 22 boys, 6% of the total; a study had taken place from 1962 to 1967 in Ypsilanti, Michigan on early years education; similar schemes in the UK were called Head Start, and the main project in the UK was HighScope, with a few schemes at primary schools funded by the Home Office. Directed by Richard Denton, produced by Geoff Deehan, made by Union Pictures 10 October In the Path of a Killer Volcano, with seismologists Dave Harlow, Richard Hoblitt, and John Ewert of the United States Geological Survey; although the biggest volcanic explosion since Krakatoa was about to occur, the seismologists at Philippine Institute of Volcanology, and Seismology (PHIVOLCS) and its director Ray Punongbayan, were mostly totally unaware of anything that abnormal; PHIVOLCS put a seismometer near the volcano, and it recorded over 400 earthquakes in just two days near the summit, so Ray Punongbayan requested urgent assistance from the US Geological Survey; Clark Air Base and U.S. Naval Base Subic Bay were around ten miles away, so seven seismic stations were in place by early May; a helicopter was flown around the site and air samples were taken for a correlation spectrometer to detect any sulphur dioxide, with the ultraviolet; Christopher G. Newhall described how sulphur dioxide detection went from 500 tonnes a day to 5000 tonnes by the end of the month; Mount Katmai in Alaska had been the 20th Century's largest volcanic explosion in early June 1912; a level-4 volcanic event is declared two days before the eruption and 120,000 people are evacuated from a 12-mile radius, but the USAF don't feel the immediate need to move; in only that same week, an eruption had been watched on Mount Unzen in Japan, and its pyroclastic flow, but those scientists who felt apparently safe when watching at close hand were caught out when the flow unexpectedly changed direction and they were trapped and were burned to death; on the morning of 10 June, the USAF base was evacuated 48 hours before the first eruption on 12 June, but the main eruption took place three days later on 15 June, with most of the scientists at the USAF base; the mud flows, known as lahar, caused the most damage by filling rivers so causing many floods; the cloud of debris would circle the globe, and reduced global average temperature by one degree over five years; the 1985 eruption of Nevado del Ruiz in Colombia had led to the Armero tragedy, killing more than 20,000 of the town's 29,000 as the eruption was not forecast. Originally a Nova documentary made in 1992, also produced by Paula S. Apsell, a joint British-American production, produced by Noel Buckner, made by WGBH
== Prevention == Dehiscence can be prevented through adequate tissue undermining to reduce stress on the wound edges, avoiding heavy lifting and speeding healing through adequate nutrition, controlling diabetes, and avoiding certain medications such as corticosteroids. Sterile strips may also be used to cover skin sutures for up to a week.
MDMA is a well-balanced serotonin–norepinephrine–dopamine releasing agent (SNDRA). (R)-MDMA and (S)-MDMA are both SNDRAs similarly. However, (R)-MDMA is several-fold less potent than (S)-MDMA in vitro and is also less potent than (S)-MDMA in vivo in non-human primates. In addition, whereas MDMA and (S)-MDMA are well-balanced SNDRAs, (R)-MDMA is comparatively much less potent as a dopamine releasing agent (~11-fold less potent in releasing dopamine than serotonin), and could be thought of instead more as a serotonin–norepinephrine releasing agent (SNRA) than as an SNDRA. In non-human primates, (S)-MDMA demonstrated significant dopamine transporter (DAT) occupancy, whereas DAT occupancy with (R)-MDMA was undetectable. Similarly, MDMA and (S)-MDMA were found to increase dopamine levels in the striatum in rodents and non-human primates, whereas (R)-MDMA did not increase striatal dopamine levels. As such, (R)-MDMA may be less psychostimulant-like than MDMA or (S)-MDMA. In addition to its actions as an SNDRA, MDMA has weak affinity for the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors, where it acts as an agonist. (R)-MDMA shows higher affinity for the serotonin 5-HT2A receptor than (S)-MDMA or MDMA. In addition, (R)-MDMA is more potent as an agonist of the serotonin 5-HT2A receptor, acting as a weak partial agonist of this receptor, whereas (S)-MDMA shows very little effect. Conversely however, (S)-MDMA is more potent as an agonist of the serotonin 5-HT2C receptor. Based on these findings, it has been hypothesized that (R)-MDMA may be more psychedelic-like than (S)-MDMA.
Sources: en.wikipedia.org
=== Homomers === An assemblage of multiple copies of a particular polypeptide chain can be described as a homomer, multimer or oligomer. Hundreds of proteins have been identified as being assembled into homomers in human cells. Homomer formation may be driven by interaction between nascent polypeptide chains as they are translated from mRNA by nearby adjacent ribosomes.
== Extraction == Extraction using superheated water tends to be fast because diffusion rates increase with temperature. Organic materials tend to increase in solubility with temperature, but not all at the same rate. For example, in extraction of essential oils from rosemary and coriander, the more valuable oxygenated terpenes were extracted much faster than the hydrocarbons. Therefore, extraction with superheated water can be both selective and rapid, and has been used to fractionate diesel and woodsmoke particulates. Superheated water is being used commercially to extract starch material from marsh mallow root for skincare applications and to remove low levels of metals from a high-temperature resistant polymer. For analytical purposes, superheated water can replace organic solvents in many applications, for example extraction of PAHs from soils and can also be used on a large scale to remediate contaminated soils, by either extraction alone or extraction linked to supercritical or wet oxidation.
David Mora, an expert at the Crisis Group analysis center, noted to AFP that due to his lack of direct succession, with his son being held in the United States, El Mencho's death created a power vacuum in the CJNG, with this power vacuum also being a major reason for the escalation in violence, stating "in the absence of a direct succession, a power vacuum is created that opens the door to violent realignments within the organization." Former DEA Chief of International Operations Mike Vigil stated to CBS News that El Mencho's death was prominent and that Mexico could seize on the moment to launch "an effective frontal assault based on intelligence," while also acknowledging that "This is a big opportunity for Mexico and the United States if they work together." El Jardinero would eventually be captured in April 2026. According to Mexican Secretary of the Navy Raymundo Pedro Morales Ángeles, El Jardinero at the time served as “the second in command of the CJNG" and had been "one of the most trusted men (of El Mencho)." However, following El Mencho's death, he also made a major attempt to seize control of the CJNG, mobilizing “personnel, weapons and resources with the aim of taking over the power of the criminal organization.”
In 1970, she began research at the Indian Institute of Technology, Kanpur (IIT Kanpur). In that year, she married Subramania Ranganathan, with whom she would go on to author Challenging problems in organic reaction mechanisms (1972), Art in biosynthesis: the synthetic chemist's challenge (1976), and Further challenging problems in organic reaction mechanisms (1980)—as well as editing an ongoing series titled "Current Organic Chemistry Highlights". She continued her research at IIT Kanpur on the basis of fellowships. Unwritten rules prevented her from joining the faculty because her husband was already a member. She began work at Regional Research Laboratory, Trivandrum in 1993, and at IICT, Hyderabad in 1998., where she became Deputy Director. During these years, she conducted ongoing collaborations with Isabella Karle at the U.S. Naval Research Laboratory. Darshan Ranganathan was diagnosed with breast cancer in 1997, and died on her 60th birthday, in 2001. The biennial "Professor Darshan Ranganathan Memorial Lecture", which is to be "delivered by a woman scientist who has made outstanding contributions in any field of Science and Technology" was established in her memory by her husband, in 2001.
=== Education === Thomson's early education was in small private schools where he demonstrated outstanding talent and interest in science. In 1870, he was admitted to Owens College in Manchester (now the University of Manchester) at the unusually young age of 14, and came under the influence of Balfour Stewart, Professor of Physics, who initiated him into physical research. He began experimenting with contact electrification and soon published his first scientific paper. His parents planned to enroll him as an apprentice engineer to Sharp, Stewart & Co, a locomotive manufacturer, but these plans were cut short when his father died in 1873. In 1876, Thomson moved on to Trinity College, Cambridge. In 1880, he received his B.A. in mathematics (Second Wrangler in the Tripos and 2nd Smith's Prizeman). He applied for and became a Fellow of Trinity College the following year. He obtained an M.A. (Adams Prizeman) in 1883.
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.
Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.
No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.
No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.